From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

News & Articles

Here you can find an extensive library of news articles, campaigns and initiatives form ASHM

Filter by​

October 2026

ASHM CEO Alexis Apostolellis announces departure

October 2026

Gallery: Pacific HIV Symposium 2026

October 2026

Discussing HIV viral load and U=U in clinical settings workshop report

October 2026

Hepatitis C and sexual health care in AOD settings workshops 

September 2026

2026 Levinia Crooks Emerging Leader Award winners announced

September 2026

Gallery: Australasian HIV&AIDS and Sexual and Reproductive Health Conferences 2026

September 2026

From uncertainty to understanding: Improving antenatal HIV services in Timor-Leste

September 2026

Pacific HIV Symposium 2026 Call to Action launched

September 2026

Important changes to Hepatitis B s100 prescriber accreditation